Krystexxa Approved for Gout
Links shared publicly online about this topic.
- 870total visits
Krystexxa Approved for Gout
View full resource at health.yahoo.net
Tags: Crystal Disorders, Gout, Drug, FDA, News
Most Recently Shared on September 16, 2010 at 4:40 am By:
Krystexxa Approved for Gout http://bit.ly/a1ycOy
Jim Belushi sings the RCG blues for Savient - Medical Marketing and Media
mmm-online.com — “Krystexxa maker Savient has recruited Jim Belushi for an awareness-raising campaign dubbed Check Out Your Gout.” View full resource at mmm-online.com
Most Recently Shared on November 9, 2011 at 9:35 pm By:
Jim Belushi sings the RCG blues for Savient: Krystexxa maker Savient has recruited Jim Belushi for an ... http://t.co/MdS1Lxdr from MM&M
Medical News: FDA Denies Biologic for Gout - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “The FDA declined to approve canakinumab (Ilaris) for treating gouty arthritis, requesting additional clinical data, the drug's manufacturer said.” View full resource at medpagetoday.com
Most Recently Shared on August 31, 2011 at 5:43 pm By:
Roger D. Jones, PhD Health Social Media, PhD, Doctor, and Health Executive
Medical News: FDA Denies Biologic for Gout - http://t.co/q8GIQSx from @medpagetoday #health #medicine
Medical News: FDA Denies Biologic for Gout - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “The FDA declined to approve canakinumab (Ilaris) for treating gouty arthritis, requesting additional clinical data, the drug's manufacturer said.” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 10:14 pm By:
Patricia Grace Eldercare Expert
FDA Denies Biologic for Gout: (MedPage Today) -- The FDA declined to approve canakinumab (Ilaris) for treating g... http://t.co/bb5M6fp
FDA Denies Biologic for Gout - QualityPoint Technologies
qualitypointtech.net — “(MedPage Today) -- The FDA declined to approve canakinumab (Ilaris) for treating gouty arthritis, requesting additional clinical data, the drug's manufacturer said.” View full resource at qualitypointtech.net
Most Recently Shared on August 29, 2011 at 9:45 pm By:
FDA Denies Biologic for Gout: (MedPage Today) -- The FDA declined to approve canakinumab (Ilaris) for treating gou... http://t.co/IPHvEU3
Medical News: FDA Denies Biologic for Gout - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “The FDA declined to approve canakinumab (Ilaris) for treating gouty arthritis, requesting additional clinical data, the drug's manufacturer said.” View full resource at medpagetoday.com
Most Recently Shared on August 29, 2011 at 9:37 pm By:
FDA Denies Biologic for Gout http://t.co/dOtLQL3
New Drug May Relieve Severe, Tough-to-Treat Gout - Gout Center - Everyday Health
everydayhealth.com — “For some gout patients afflicted with a particularly severe, crippling form of the disease who find standard treatments either intolerable or ineffective, a recently approved alternative appears to afford relief.” View full resource at everydayhealth.com
Most Recently Shared on August 17, 2011 at 8:10 pm By:
Tough-to-treat Gout? There's a new drug that may finally be the answer: http://ow.ly/65F3l
Medical News: Enzyme Works for Hard-to-Treat Gout - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “The intravenous enzyme pegloticase (Krystexxa) is an effective therapy for many people whose gout doesn't respond to conventional treatment, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on August 17, 2011 at 7:00 pm By:
Roger D. Jones, PhD Health Social Media, PhD, Doctor, and Health Executive
Enzyme Works for Hard-to-Treat Gout - in Rheumatology, General Rheumatology from MedPage Today - http://t.co/YCb597R from @medpagetoday
Savient aims for primary care with new Krystexxa data - FiercePharma
fiercepharma.com — “Savient Pharmaceuticals ($SVNT) hasn't made huge inroads with its new gout drug, Krystexxa. Over the first 6 months of the year, the drug generated only $1.4 million in sales. But the company is now Read more...” View full resource at fiercepharma.com
Most Recently Shared on August 17, 2011 at 5:10 pm By:
Drugs and Devices OW OW Health
Savient aims for primary care with new Krystexxa data - FiercePharma: ThirdAgeSavient aims for primary car... http://t.co/pe7QwN4 #drug
Savient Pharmaceuticals Announces Publication of Pivotal Phase III Krystexxa Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients - Drugs.com MedNews
drugs.com — “Pooled data from two Phase III studies demonstrated that 42 percent of refractory chronic gout (RCG) patients treated with KRYSTEXXA every two weeks achieved st” View full resource at drugs.com
Most Recently Shared on August 17, 2011 at 4:16 pm By:
Drugs and Devices OW OW Health
Savient Pharmaceuticals Announces Publication of Pivotal Phase III Krystexxa Data in JAMA Demonstrating Si... http://t.co/fbOgYy5 #drug
Medical News: Enzyme Works for Hard-to-Treat Gout - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “The intravenous enzyme pegloticase (Krystexxa) is an effective therapy for many people whose gout doesn't respond to conventional treatment, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 8:21 pm By:
Enzyme Works for Hard-to-Treat Gout (CME/CE) http://t.co/BoGgb8X
Medical News: Enzyme Works for Hard-to-Treat Gout - in Rheumatology, General Rheumatology from MedPage Today
medpagetoday.com — “The intravenous enzyme pegloticase (Krystexxa) is an effective therapy for many people whose gout doesn't respond to conventional treatment, researchers reported.” View full resource at medpagetoday.com
Most Recently Shared on August 16, 2011 at 8:16 pm By:
Krystexxa works for hard-to-treat #gout http://t.co/ouCiGWn
FDA Panel Rejects Gout Drug on Safety Concerns
arthritis.webmd.com — “Safety concerns led an FDA advisory panel to oppose approval of a new drug for gout, despite widespread enthusiasm for the medication's effectiveness against the painful disorder.” View full resource at arthritis.webmd.com
Most Recently Shared on June 21, 2011 at 11:27 pm By:
FDA Panel Rejects Gout Drug on Safety Concerns http://bit.ly/k5EBX2 #rn #health #nursing
Medical News: FDA Panel Calls Biologic Drug Unsafe for Gout - in Rheumatology, Arthritis from MedPage Today
medpagetoday.com — “The biologic drug canakinumab (Ilaris) is effective in treating acute flares of gouty arthritis but is too risky to warrant approval, members of the FDA's Arthritis Advisory Committee said Tuesday.” View full resource at medpagetoday.com
Most Recently Shared on June 21, 2011 at 10:17 pm By:
FDA Panel Calls Biologic Drug Unsafe for Gout: (MedPage Today) -- The biologic drug… http://goo.gl/fb/bqREL
Medical News: FDA Panel Calls Biologic Drug Unsafe for Gout - in Rheumatology, Arthritis from MedPage Today
medpagetoday.com — “The biologic drug canakinumab (Ilaris) is effective in treating acute flares of gouty arthritis but is too risky to warrant approval, members of the FDA's Arthritis Advisory Committee said Tuesday.” View full resource at medpagetoday.com
Most Recently Shared on June 21, 2011 at 9:04 pm By:
FDA Panel Calls Biologic Drug Unsafe for Gout http://bit.ly/lUIre4
Got The Gout? Novartis Sees Positive Results From Ilaris Treatment
medicalnewstoday.com — “Novartis is happy with results of new testing that supports approval of gout, or gouty arthritis treatment which is already in the review pipeline according to a new release this week by the Swiss” View full resource at medicalnewstoday.com
Most Recently Shared on May 25, 2011 at 6:05 pm By:
Got The Gout? Novartis Sees Positive Results From Llaris Treatment http://mnt.to/3Wm6 #gout
Advertisement
